Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer

James M. Clark, Laurence J. Heifetz, Daphne Palmer, Lisa M Brown, David T Cooke, Elizabeth David

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.

Original languageEnglish (US)
Pages (from-to)139-142
Number of pages4
JournalCancer Treatment and Research Communications
Volume9
DOIs
StatePublished - Jan 1 2016

Fingerprint

Telemedicine
Non-Small Cell Lung Carcinoma
Clinical Trials
Rural Population
Tertiary Care Centers
Brain Neoplasms
Therapeutics
Neoplasm Metastasis
Survival
Neoplasms

Keywords

  • Clinical trial
  • Non-small cell lung cancer (NSCLC)
  • Rural health
  • Telemedicine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{8bcd795a3b1e447aa6fb8b2af4301b6b,
title = "Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer",
abstract = "Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.",
keywords = "Clinical trial, Non-small cell lung cancer (NSCLC), Rural health, Telemedicine",
author = "Clark, {James M.} and Heifetz, {Laurence J.} and Daphne Palmer and Brown, {Lisa M} and Cooke, {David T} and Elizabeth David",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.ctarc.2016.09.005",
language = "English (US)",
volume = "9",
pages = "139--142",
journal = "Cancer Treatment and Research Communications",
issn = "2213-0896",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer

AU - Clark, James M.

AU - Heifetz, Laurence J.

AU - Palmer, Daphne

AU - Brown, Lisa M

AU - Cooke, David T

AU - David, Elizabeth

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.

AB - Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.

KW - Clinical trial

KW - Non-small cell lung cancer (NSCLC)

KW - Rural health

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=85034085335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034085335&partnerID=8YFLogxK

U2 - 10.1016/j.ctarc.2016.09.005

DO - 10.1016/j.ctarc.2016.09.005

M3 - Article

VL - 9

SP - 139

EP - 142

JO - Cancer Treatment and Research Communications

JF - Cancer Treatment and Research Communications

SN - 2213-0896

ER -